abstract |
The present application provides a pharmaceutical composition for administration to a patient suffering from at least one symptom of cardiovascular disease, the composition comprising a) an activated-enhanced form of an antibody against angiotensin II AT1 receptor, and b) endothelial NO- Activated-enhanced forms of antibodies against synthase. |